“It’s been 40 years since Mr. McGuire pulled Benjamin Braddock aside at his graduation party and said, “I just want to say one word to you. Just one word … Are you listening? … Plastics. There’s a great future in plastics.” ¹
¹Denise Ryan, NERAC.com
1 Comment | 
Analyst, BCC Research, Business, diagnostics, Environment, markets, Science, Technology | Tagged: BCC, Bioplastics, CAGR, ROI, The Graduate | 
Permalink
Posted by BCC Research
The value of the global market for process spectroscopy is projected to reach $1.2 billion in 2008, up from $945.9 million in 2006, according to a technical market research report from BCC Research, based in Wellesley, Mass. The value is expected to reach $1.9 billion by 2013, with a compound annual growth rate (CAGR) of 8.5 percent.
The worth of the equipment segment, which has the largest share of the market, is estimated at $957.8 million in 2008 and is expected to reach $1.4 billion in 2013, with a CAGR of 8.2 percent. The value of the applications segment, expected to be $282.6 million in 2008, should rise to $445.3 million in five years, with a CAGR of 9.5 percent.
Raman demand up
The demand for diode array and Raman scattering spectrometers is expected to grow rapidly between 2008 and 2013. The market for diode array spectrometers, which increasingly are being used in process spectroscopy, is projected to have a CAGR of 36.6 percent, and the market for Raman scattering spectrometers, a growth rate of 14 percent.
Published in May 2008, the report, “Process Spectroscopy: the Global Market” (IAS008C), is an update of the company’s 2005 report on the market (G-228R). It includes descriptions of process spectroscopy technologies, trends and forecasts for their growth over the next five years, and of discussions on anticipated innovations and new applications. Regulatory factors as they apply to applications are examined, and company profiles, including information on mergers or acquisitions, are included.
The analysis across the process spectroscopy market is based partly on reported revenue dollars and units as reported to the US Securities and Exchange Commission and/or other governmental agencies, as well as on previous process spectroscopy reports and on data gathered from various sources, including US Patent and Trademark Office databases. ¹
¹Caren B. Les; Photonics.com
Leave a Comment » | BCC Research | Tagged: BCC, BCC Research, CAGR, energy, market, photonics, Photovoltaics, Process Spectroscopy, Solar | Permalink
Posted by BCC Research
Wellesley, MA – According to a new technical market research report from BCC Research titled “DNA Sequencing: Emerging technologies and Applications,” the global market for DNA sequencing technology was worth $794.0 million in 2007 and an estimated $862.5 million in 2008. This should increase to $1.7 billion by 2013, a compound annual growth rate (CAGR) of 14.7%.
The market is broken down into the segments of research/drug discovery and development, commercial applications and emerging applications.
Research/drug discovery and development has the largest share of the market, generating $600.4 million in 2007. This is expected to increase to $640.6 million in 2008 and over $1.0 billion in 2013, for a CAGR of 9.7%.
Commercial applications have the next largest share of the market, worth $193.6 million in 2007 and an estimated $218.8 million in 2008. This should increase at a CAGR of 14.3% to reach $426.1 million in 2013.
Emerging applications have the smallest but fastest growing share of the market. This sector is expected to generate $3.1 million by the end of 2008 and $272.5 million in 2013, for a CAGR of 144.8%. DNA sequencing allows us to catalogue the variations within the human genome sequence that make us phenotypically different, and that cause resistance and susceptibility to disease.
The rapidly evolving sequencing technologies provide unprecedented analytical tools that allow us to identify this sequence variation, in humans as well as in other species. Technology and market forces are working a fundamental shift in the DNA sequencing industry away from stagnant/declining growth towards high growth.
This growth inflection signals the arrival of DNA sequencing as a premier genetic analysis tool: useful for existing applications such as de novo whole genome sequencing and entirely new applications like epigenetic tag sequencing.¹
¹OBBeC.com
2 Comments | BCC Research, biotechnology | Tagged: BCC, BCC Research, CAGR, Consulting, de novo whole genome, DNA, dna sequencing, epigenetic tag sequencing, genome, human genome, Research, Wellesley | Permalink
Posted by BCC Research
Wellesley, Mass—According to a new technical market research report, DNA SEQUENCING: EMERGING TECHNOLOGIES AND APPLICATIONS (BIO045B) from BCC Research, the global market for DNA sequencing technology was worth $794.0 million in 2007 and an estimated $862.5 million in 2008. This should increase to $1.7 billion by 2013, a compound annual growth rate (CAGR) of 14.7%.
The market is broken down into the segments of research/drug discovery and development, commercial applications and emerging applications. Research/drug discovery and development has the largest share of the market, generating $600.4 million in 2007. This is expected to increase to $640.6 million in 2008 and over $1.0 billion in 2013, for a CAGR of 9.7%.
Commercial applications have the next largest share of the market, worth $193.6 million in 2007 and an estimated $218.8 million in 2008. This should increase at a CAGR of 14.3% to reach $426.1 million in 2013.
Emerging applications have the smallest but fastest growing share of the market. This sector is expected to generate $3.1 million by the end of 2008 and $272.5 million in 2013, for a CAGR of 144.8%.
DNA sequencing allows us to catalogue the variations within the human genome sequence that make us phenotypically different, and that cause resistance and susceptibility to disease. The rapidly evolving sequencing technologies provide unprecedented analytical tools that allow us to identify this sequence variation, in humans as well as in other species.
Technology and market forces are working a fundamental shift in the DNA sequencing industry away from stagnant/declining growth towards high growth. This growth inflection signals the arrival of DNA sequencing as a premier genetic analysis tool: useful for existing applications such as de novo whole genome sequencing and entirely new applications like epigenetic tag sequencing.
FIGURE
GLOBAL VALUE OF DNA SEQUENCING, BY END USE APPLICATION,
2006-2013
($ millions)
1 Comment | BCC Research, biotechnology | Tagged: BCC, BCC Research, biotech, biotechnology, CAGR, de novo whole, DNA, drugs, epigenetic tag, genome sequencing, health, healthcare, Pharmaceuticals | Permalink
Posted by BCC Research
FOR IMMEDIATE RELEASE
July 30, 2008
Contact: Jason W. Prokowiew
Tel: 978-870-3345
Email: jason.prokowiew@bccresearch.com
GLOBAL MARKET FOR PORTABLE BATTERY POWERED PRODUCTS WORTH $461.5 BILLION BY 2013
Wellesley, Mass—According to a new technical market research report, PORTABLE BATTERY-POWERED PRODUCTS: GLOBAL MARKETS (FCB023D) from BCC Research, the global market for portable battery-powered products was worth $425.3 billion in 2007. This is expected to increase to $443.2 billion in 2008 and $461.5 billion by the end of 2013, a compound annual growth rate (CAGR) of 0.8%.
The market is broken down into applications for communication, entertainment, computer, navigation, camera, timepiece, tools, lighting, toy and novelty, medical, scientific and military. Of these, communication products have the largest share of the market. Valued at $127.6 billion in 2007 and an estimated $135.2 billion in 2008, this segment is expected to decline to $120.0 billion in 2013, a CAGR of –2.3%. This decline is due to a convergence of function seen in PDAs and smartphones that causes individual markets to shrink as new converged markets grow.
Computer products, the second largest segment, was worth $98.0 billion in 2007. It is expected to reach $103.0 billion in 2008 and $118.7 billion in 2013, for a CAGR of 2.8%. Medical products also represent a significant share of the market, generating $66.1 billion in 2007 and an estimated $68.6 billion in 2008. This should increase to $94.0 billion in 2013, for a CAGR of 6.5%.
The fastest growing segment is expected to be military products. This segment was worth $1.3 billion in 2007 and is expected to increase to $1.8 billion in 2008 and $3.2 billion in 2013, a CAGR of 12.0%.
The key technology that enables these portable products is the $72 billion worth of batteries used to provide power. Although advanced high-energy battery systems, like lithium-ion and nickel-metal-hydride, have gained the most attention, primary alkaline batteries are still widely used. Battery chargers remain a smaller market. In 2007, 2.1 billion internal and external battery chargers worth $43 billion were used with portable battery-powered products.
4 Comments | BCC Research, Fuel Cell and Batteries | Tagged: batteries, battery, BCC, BCC Research, CAGR, camera, communication, computer, entertainment, Fuel cells, lighting, medical, military, navigation, PDAs, portable battery, scientific, Smart Phones, timepiece, tools, toy and novelty | Permalink
Posted by BCC Research
According to a new technical market research report, MEMBRANE BIOREACTORS: GLOBAL MARKETS (MST047B) from BCC Research, the global market for membrane bioreactor technology is expected to grow at a compound annual growth rate (CAGR) of 10.5%, increasing in value from $296.0 million in 2008 to $488.0 million by 2013.¹
¹BCC Research; Wateronline.com
2 Comments | BCC Research, MST | Tagged: BCC, BCC Research, CAGR, Membrane, Membrane Bioreactors, Membrane separation technology, MST, MST047B, waste water, Wastewater, Water | Permalink
Posted by BCC Research
According to a new technical market research report, GLOBAL PHARMACEUTICAL MARKETS (PHM037B) from BCC Research, the global market for pharmaceuticals was worth $693.6 billion in 2007. This is expected to increase to $737.6 billion in 2008 and reach over $1.0 trillion in 2013, a compound annual growth rate (CAGR) of 6.9%.
The market is broken down into applications of branded prescription drugs, generic prescription drugs and over-the-counter (OTC) products. Of these, branded prescription drugs have the largest share of the market. Worth an estimated $525.1 billion in 2007, this segment is expected to grow to a value of $553.2 billion in 2008 and $741.5 billion by the end of 2013, for a CAGR of 6.0%.
The second largest segment, generic prescription drugs, will experience the highest growth rate over the study period. Worth $78.5 billion in 2007 and an estimated $88.7 billion in 2008, it will reach $151.4 billion by the end of 2013, for a CAGR of 11.3%.
The OTC segment was worth over $90.0 billion in 2007. It should increase to $95.7 billion in 2008 and reach $135.1 billion in 2013, for a CAGR of 7.1%.
Though the worldwide pharmaceutical industry remains one of the most profitable and stable industries, several variables are influencing fundamental changes in its structure including increasing examples of government-imposed price reductions in pharmaceutical prices, the increasing role of generic substitutes, and enhanced outsourcing, in-licensing, contract research and manufacturing activities.
Increased health awareness amongst patients and governments, changing world demographics, declining R&D productivity, worldwide compliance of general agreements on tariffs and trade (GATT) and trade related intellectual property rights (TRIPS), along with the emergence of e-pharmaceuticals also are reshaping the dynamic pharmaceuticals industry.¹
¹BCC Research
1 Comment | BCC Research, Pharmaceuticals | Tagged: BCC, BCC Research, CAGR, pharma, Pharma Market, Pharmaceuticals, PHM037B | Permalink
Posted by BCC Research
